Zentalis Pharmaceuticals Announces Poster Presentation at ASCO 2025 on Azenosertib for Colorectal Cancer April 23, 2025 — 04:15 pm EDT Written by None for Quiver Quantitative -> ...

The poster presentation will provide further details regarding the positive safety and pharmacokinetic (PK) data from the Company’s first part of its two-part Phase 3 clinical trial of PRF-110 ...